![Researchers review data on a laptop in the lab](https://www.uc.edu/news/articles/2023/02/n21146103/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1675874776083.jpg)
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
Local 12 recently highlighted University of Cincinnati Cancer Center researcher Andrew Waters, PhD.
Waters specializes in pancreatic cancer research, and the National Cancer Institute recently announced an intent to fund research in his lab focused on treatments that target KRAS-mutated pancreatic cancer.
Waters said the KRAS gene is like a light switch. When mutated, it is left on and causes cells to divide and grow uncontrollably. The first line of drugs targeting KRAS has been approved for different cancers, but they target a mutation not often found in pancreatic cancer.
"A focus of my research lab and other labs and others around the country is really trying to use pre-clinical and clinical drugs that target the other 98-99 percent of pancreatic cancer patients," Waters told Local 12.
"The other main focus of my lab is really trying to address this relapse," he continued. "So, when KRAS drugs are available for pancreatic cancer patients, how are these cells going to be able to adapt? And how can we cut off those adaptation mechanisms with another FDA-approved drug?"
Watch the Local 12 story on Waters' research.
Waters was also featured in a Local 12 story about a woman raising money for pancreatic cancer research. Watch the story.
Read more about Waters' research.
Featured photo at top: Researchers Krushna Patra, Andrew Waters and Patrick Krause review data. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
GEN News: Biomarker discovery to help predict breast cancer outcomes
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
Laser Focus World highlights UC research that uses light to restore cell function
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
Medium highlights UC research of light as treatment for cancer
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
Local 12 highlights Pancreatic Cancer Awareness Month
November 27, 2023
Local 12 recently spoke with the University of Cincinnati's Andrew Waters and Pancreatic Cancer Action Network volunteers to discuss ongoing pancreatic cancer research and funding support during Pancreatic Cancer Awareness Month.
Research Evangelist: UC expert discusses improving accessibility to lung cancer treatments
November 28, 2023
The University of Cincinnati Cancer Center's Robert Van Haren joined the Research Evangelist podcast to discuss advancements in lung cancer care and research to improve accessibility to treatments.
Local 12: Breakthrough device guides surgeons in locating breast cancer tumors
November 6, 2023
Local 12 highlighted research from the University of Cincinnati Cancer Center that found a seed device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
55KRC: UC research advances view at the subcellular level
March 15, 2022
55KRC featured University of Cincinnati researcher Jiajie Diao on the Simply Medicine program to discuss advances in a new probe and imaging technique to get a better view of human cells.
Medical News Today: Parabens may increase breast cancer risk in Black women
June 23, 2022
The University of Cincinnati's Xiaoting Zhang reviewed a new study for Medical News Today that found certain parabens may increase breast cancer risk for Black women.
The Cancer Letter highlights UC kidney cancer research
January 23, 2024
The Cancer Letter highlighted the University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska's new NIH-funded research that will investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.